Elanco Animal Health Inc Quarterly Interest Expense in USD from Q1 2017 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of the cost of borrowed funds accounted for as interest expense.
Summary
Elanco Animal Health Inc quarterly/annual Interest Expense history and growth rate from Q1 2017 to Q3 2024.
  • Elanco Animal Health Inc Interest Expense for the quarter ending September 30, 2024 was $58M, a 19.4% decline year-over-year.
  • Elanco Animal Health Inc Interest Expense for the twelve months ending September 30, 2024 was $256M, a 5.88% decline year-over-year.
  • Elanco Animal Health Inc annual Interest Expense for 2023 was $277M, a 14.9% increase from 2022.
  • Elanco Animal Health Inc annual Interest Expense for 2022 was $241M, a 2.12% increase from 2021.
  • Elanco Animal Health Inc annual Interest Expense for 2021 was $236M, a 57.3% increase from 2020.
Interest Expense, Trailing 12 Months (USD)
Interest Expense, Quarterly (USD)
Interest Expense, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 $256M $58M -$14M -19.4% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-07
Q2 2024 $270M $65M -$9M -12.2% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-08
Q1 2024 $279M $66M +$2M +3.13% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-08
Q4 2023 $277M $67M +$5M +8.07% Oct 1, 2023 Dec 31, 2023 10-K 2024-02-26
Q3 2023 $272M $72M +$12M +20% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-07
Q2 2023 $260M $74M +$7M +10.4% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-08
Q1 2023 $253M $64M +$12M +23.1% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-08
Q4 2022 $241M $62M +$7M +12.7% Oct 1, 2022 Dec 31, 2022 10-K 2024-02-26
Q3 2022 $234M $60M $0 0% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-07
Q2 2022 $234M $67M +$7M +11.7% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-07
Q1 2022 $227M $52M -$9M -14.8% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-09
Q4 2021 $236M $55M -$5.4M -8.94% Oct 1, 2021 Dec 31, 2021 10-K 2024-02-26
Q3 2021 $241M $60M +$12M +25% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-08
Q2 2021 $229M $60M +$35M +140% Apr 1, 2021 Jun 30, 2021 10-K 2023-03-01
Q1 2021 $194M $61M +$45M +281% Jan 1, 2021 Mar 31, 2021 10-K 2023-03-01
Q4 2020 $149M $60.4M +$41.7M +223% Oct 1, 2020 Dec 31, 2020 10-K 2021-03-01
Q3 2020 $108M $48M +$29.3M +157% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-05
Q2 2020 $78.4M $25M +$4.3M +20.8% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-09
Q1 2020 $74.1M $16M -$4.8M -23.1% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-07
Q4 2019 $78.9M $18.7M -$2.3M -11% Oct 1, 2019 Dec 31, 2019 10-K 2021-03-01
Q3 2019 $81.2M $18.7M +$10.1M +117% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-06
Q2 2019 $71.1M $20.7M +$20.7M Apr 1, 2019 Jun 30, 2019 10-Q 2020-07-30
Q1 2019 $50.4M $20.8M +$20.8M Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-07
Q4 2018 $29.6M $21M +$21M Oct 1, 2018 Dec 31, 2018 10-K 2020-02-28
Q3 2018 $8.6M $8.6M +$8.6M Jul 1, 2018 Sep 30, 2018 10-K 2020-02-28
Q2 2018 $0 $0 $0 Apr 1, 2018 Jun 30, 2018 10-K 2020-02-28
Q1 2018 $0 $0 $0 Jan 1, 2018 Mar 31, 2018 10-K 2020-02-28
Q4 2017 $0 $0 Oct 1, 2017 Dec 31, 2017 10-K 2019-02-20
Q3 2017 $0 Jul 1, 2017 Sep 30, 2017 10-K 2019-02-20
Q2 2017 $0 Apr 1, 2017 Jun 30, 2017 10-K 2019-02-20
Q1 2017 $0 Jan 1, 2017 Mar 31, 2017 10-K 2019-02-20
* An asterisk sign (*) next to the value indicates that the value is likely invalid.